RxSight, Inc. increased earnings guidance for the full year 2024. For the year, the company expected revenue of $132.0 million to $137.0 million, representing implied growth of 48% to 54% compared to 2023, up from prior guidance of $128.0 million to $135.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
57.52 USD | -2.43% | +1.72% | +42.66% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.66% | 2.3B | |
-3.87% | 187B | |
-0.52% | 109B | |
-3.65% | 69.22B | |
-5.79% | 46.36B | |
+13.26% | 46.19B | |
+8.48% | 42.44B | |
+18.83% | 30.84B | |
+19.69% | 25.73B | |
-6.80% | 23.3B |
- Stock Market
- Equities
- RXST Stock
- News RxSight, Inc.
- RxSight, Inc. Increases Earnings Guidance for the Full Year 2024